To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Strain ID |
Strain Descriptor |
Associated gene(s) |
Phenotypes |
| DBS0266719 | Dd5P4-/ [act15]: Dd5P4: GFP | Dd5P4 | wild type |
| DBS0266695 | Dd5P4-/ [act15]: GAP5P4 | Dd5P4 | decreased growth rate, multiple tips in mound |
| DBS0266720 | Dd5P4-/ [act15]: Hs-OCRL | Dd5P4 | decreased phagocytosis |
| DBS0266721 | Dd5P4-/ [act15]: Hs-OCRL(D422A) | Dd5P4 | decreased phagocytosis |
| DBS0266694 | Dd5P4-/ [act15]: cat5P4 | Dd5P4 | decreased growth rate, multiple tips in mound |
| CW0391 | FLAG-VwkA | vwkA | aberrant cytokinesis, decreased growth rate in suspension, development arrests at mound stage, increased myosin II assembly, increased protein level |
| DBS0238036 | [AS]proA/ proB-/ [act15]: proA | proA, proB | wild type |
| DBS0238037 | [AS]proA/ proB-/ [act15]: proB | proA, proB | wild type |
| DBS0238035 | [AS]proA/ proB-/ [unk]: FLAG: proC | proA, proB, proC | wild type |
| DBS0237274 | [OE]: chlim | ChLim | decreased growth rate, decreased phagocytosis, increased basal F-actin level |
| DBS0302602 | [OE]: disgorgin(Delta-Fbox)/ disgorgin- | DDB_G0280955 | wild type |
| DBS0302601 | [OE]: disgorgin(Q551A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0302600 | [OE]: disgorgin(R515A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0302599 | [OE]: disgorgin/ disgorgin- | DDB_G0280955 | wild type |
| DBS0302610 | [OE]: disgorgin/ phgA- | DDB_G0280955, phgA | aberrant contractile vacuole organization and biogenesis |
| JH258 | [OE]: gpaE | gpaE | precocious gene expression, precocious tip formation |
| DBS0302611 | [OE]: phgA/ disgorgin- | DDB_G0280955, phgA | aberrant contractile vacuole organization and biogenesis |
| DBS0302681 | [OE]: sgcA(878-2843): GFP/ sgcA- | gcA, sgcA | decreased chemotaxis rate |
| DBS0302682 | [OE]: sgcA(N1106A): GFP/ gca-/ sgcA- | gcA, sgcA | aberrant streaming, decreased chemotaxis rate, increased lateral pseudopod formation |
| DBS0266512 | [act15]: DDB_G0272656 | DDB_G0272656 | wild type |
| DBS0238107 | [act15]: FLAG: ppp4C | ppp4c | wild type |
| DBS0238108 | [act15]: FLAG: ppp4C(H113Q) | ppp4c | delayed development, development arrests at mound stage |
| DBS0304572 | [act15]: GFP: abpD(1441-1736) | abpD | abolished localization of a protein to the nuclear envelope |
| DBS0304571 | [act15]: GFP: abpD(1441-1738) | abpD | abolished localization of a protein to the nuclear envelope |
| DBS0304573 | [act15]: GFP: abpD(1441-1738, 1737P/ A) | abpD | abolished localization of a protein to the nuclear envelope |
| DBS0237114 | [act15]: GFP: abpE(413-481) | abpE-1, abpE-2 | increased lateral pseudopod formation |
| DBS0235662 | [act15]: GFP: forH(1-425) | forH | aberrant protein localization |
| DBS0304973 | [act15]: GFP: gefQ(173-651, 818-1298) | gefQ | increased Ras guanyl-nucleotide exchange factor activity |
| DBS0304971 | [act15]: GFP: gefQ(683-833) | gefQ | decreased Ras guanyl-nucleotide exchange factor activity |
| DBS0304972 | [act15]: GFP: gefQ(910-1298) | gefQ | aberrant cytokinesis, aberrant phototaxis |
| DBS0236070 | [act15]: GFP: hcpA | hcpA | aberrant anaphase, decreased growth rate in suspension |
| DBS0237117 | [act15]: GFP: krsA | krsA | decreased slug migration |
| DBS0237118 | [act15]: GFP: limE | limE | aberrant cytokinesis |
| DBS0237122 | [act15]: GFP: pats1(2087-2351) | pats1 | aberrant cytokinesis |
| DBS0237123 | [act15]: GFP: phg2(1-245) | phg2 | decreased phagocytosis |
| DBS0237702 | [act15]: GFP: rac1A | rac1A | increased filopodium formation, increased membrane ruffling |
| DBS0237703 | [act15]: GFP: rac1B | rac1B | increased filopodium formation, increased membrane ruffling |
| DBS0237704 | [act15]: GFP: rac1C | rac1C | increased filopodium formation, increased membrane ruffling |
| DBS0237125 | [act15]: GFP: racG(1-168): racH(164-200) | racG, racH | decreased chemoattractant-mediated F-actin polymerization, decreased phagocytosis, increased filopodium formation |
| DBS0237128 | [act15]: GFP: racH(1-163): racG(167-201) | racG, racH | decreased chemoattractant-mediated F-actin polymerization |
| DBS0237130 | [act15]: GFP: racH(M13V) | racH | aberrant cell morphology, aberrant cytokinesis, increased F-actin polymerization |
| DBS0237132 | [act15]: GFP: racH(T18N) | racH | aberrant cell morphology, aberrant cytokinesis |
| DBS0237133 | [act15]: GFP: racH: gemA(630-658) | gemA, racH | delayed cytokinesis |
| DBS0238392 | [act15]: GFP: rapA | rapA | increased cell-substrate adhesion |
| DBS0238393 | [act15]: GFP: rapA(G12V) | rapA | increased cell-substrate adhesion |
| DBS0238394 | [act15]: GFP: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0237134 | [act15]: GFP: sbds | sbds | wild type |
| DBS0237135 | [act15]: GFP: sbds | sbds | wild type |
| DBS0304563 | [act15]: GFP: sun1(283-905) | sun1 | aberrant centrosome localization, aberrant nucleus morphology, aberrant perinuclear space, aberrant sister chromosome segregation, decreased localization of a protein to the nuclear envelope, increased cell size, increased number of centrosomes |
| DBS0238111 | [act15]: HA: smkA | smkA | decreased cell polarity, decreased chemotaxis to cAMP, decreased fruiting body size, delayed development |
| DBS0237817 | [act15]: YFP: wipA | wipA | increased F-actin polymerization at the leading edge, increased filopodium formation |
| DBS0237819 | [act15]: YFP: wipA(K36A) | wipA | increased F-actin polymerization at the leading edge, increased filopodium formation |
| DBS0237821 | [act15]: YFP: wipA(K93A/ S95A) | wipA | increased F-actin polymerization at the leading edge, increased filopodium formation |
| DBS0304574 | [act15]: abpD | abpD | abolished localization of a protein to the nuclear envelope |
| DBS0237096 | [act15]: abpE | abpE-1, abpE-2 | aberrant aggregation, decreased cell motility, decreased fruiting body size, delayed development, increased lateral pseudopod formation |
| DBS0238086 | [act15]: atg1 | atg1 | wild type |
| DBS0238091 | [act15]: atg1(1-628) | atg1 | wild type |
| DBS0238088 | [act15]: atg1(K36A) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation, abolished macroautophagy, increased number of autophagosomes |
| DBS0238090 | [act15]: atg1(K36A/ 1-628) | atg1 | wild type |
| DBS0252737 | [act15]: carA(I104A) | carA-1, carA-2 | decreased cAMP binding |
| DBS0252732 | [act15]: carA(I104C) | carA-1, carA-2 | decreased MAP kinase activation |
| DBS0252740 | [act15]: carA(I104D) | carA-1, carA-2 | aberrant cAMP wave formation, decreased MAP kinase activation, delayed aggregation, increased cAMP binding |
| DBS0252744 | [act15]: carA(I104E) | carA-1, carA-2 | aberrant cAMP wave formation, delayed aggregation, increased cAMP binding |
| DBS0252741 | [act15]: carA(I104F) | carA-1, carA-2 | decreased MAP kinase activation, increased cAMP binding |
| DBS0252738 | [act15]: carA(I104G) | carA-1, carA-2 | decreased MAP kinase activation, increased cAMP binding |
| DBS0252747 | [act15]: carA(I104H) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252749 | [act15]: carA(I104K) | carA-1, carA-2 | abolished aggregation, abolished cAMP wave formation, decreased MAP kinase activation, increased cAMP binding |
| DBS0252739 | [act15]: carA(I104L) | carA-1, carA-2 | wild type |
| DBS0252742 | [act15]: carA(I104M) | carA-1, carA-2 | increased cAMP binding |
| DBS0252746 | [act15]: carA(I104N) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252734 | [act15]: carA(I104P) | carA-1, carA-2 | decreased MAP kinase activation |
| DBS0252745 | [act15]: carA(I104Q) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252750 | [act15]: carA(I104R) | carA-1, carA-2 | abolished cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0252743 | [act15]: carA(I104S) | carA-1, carA-2 | aberrant cAMP wave formation, decreased MAP kinase activation, increased cAMP binding |
| DBS0252735 | [act15]: carA(I104T) | carA-1, carA-2 | aberrant cAMP wave formation, increased cAMP binding |
| DBS0252736 | [act15]: carA(I104V) | carA-1, carA-2 | wild type |
| DBS0252733 | [act15]: carA(I104W) | carA-1, carA-2 | increased cAMP binding |
| DBS0252748 | [act15]: carA(I104Y) | carA-1, carA-2 | aberrant cAMP wave formation, decreased MAP kinase activation, development arrests at loose aggregate stage, increased cAMP binding |
| DBS0302445 | [act15]: cfaD | cfaD | aberrant fruiting body morphology, decreased growth rate |
| DBS0302656 | [act15]: cnrN/ cnrN- | cnrN | wild type |
| DBS0302658 | [act15]: cnrN/ smlA- | cnrN, smlA | decreased fruiting body size |
| DBS0237102 | [act15]: cofA | cofA | increased actin bundle formation, increased cell motility, increased membrane ruffling |
| DBS0237104 | [act15]: dagA | dagA | wild type |
| DBS0237106 | [act15]: dhkC(394-661) | dhkC | increased slug migration |
| DBS0235716 | [act15]: dhkK | dhkK | development arrests at mound stage, precocious aggregation |
| DBS0235705 | [act15]: dhkK(D1125N) | dhkK | aberrant cAMP signaling during aggregation, delayed development |
| DBS0235707 | [act15]: dhkK(H825Q) | dhkK | decreased fruiting body size, precocious development |
| DBS0235709 | [act15]: dhkK(H825Q/ D1125N) | dhkK | aberrant slug migration, delayed culmination |
| DBS0237108 | [act15]: fbxA: FLAG | fbxA | decreased prespore cell differentiation |
| DBS0235979 | [act15]: fszA: GFP | fszA | increased number of tubular mitochondria |
| DBS0237136 | [act15]: gpaA | gpaA | aberrant cytokinesis, aberrant fruiting body morphology, increased stalk length |
| DBS0252821 | [act15]: hssA | hssA | wild type |
| DBS0237203 | [act15]: mhkB: FLAG | mhkB | aberrant cytokinesis, decreased myosin II assembly |
| DBS0237162 | [act15]: myc-cdk8 | cdk8 | multiple tips |
| DBS0266839 | [act15]: myc: ptpΔ(3C649S) | ptpC | aberrant localization of protein to the nucleus, increased protein tyrosine phosphorylation |
| DBS0266837 | [act15]: myc: ptpC | ptpC | aberrant protein localization, aberrant response to hyperosmotic stress, aberrant signal transduction during aggregation |
| DBS0266838 | [act15]: myc: ptpC(C649S) | ptpC | aberrant localization of protein to the nucleus, increased protein tyrosine phosphorylation |
| DBS0238398 | [act15]: myc: rapA | rapA | aberrant cell morphology, decreased cell motility, increased cell-substrate adhesion |
| DBS0238396 | [act15]: myc: rapA(G12V) | rapA | decreased cell motility, delayed aggregation, increased cell-substrate adhesion |
| DBS0238397 | [act15]: myc: rapA(S17N) | rapA | decreased cell-substrate adhesion |
| DBS0237167 | [act15]: myc: rckA | rckA | delayed development |
| DBS0237163 | [act15]: myc: rckA(C551A) | rckA | decreased chemotaxis rate, delayed slug formation |
| DBS0237164 | [act15]: myc: rckA(E510G) | rckA | decreased chemotaxis rate, delayed slug formation |
| DBS0237165 | [act15]: myc: rckA(E510G/ N511A) | rckA | decreased chemotaxis rate, delayed slug formation |
| DBS0237166 | [act15]: myc: rckA(K867A) | rckA | decreased chemotaxis rate, delayed slug formation, precocious aggregation |
| DBS0237179 | [act15]: myr: rckA | rckA | decreased chemotaxis rate, delayed development |
| DBS0237180 | [act15]: nramp1: GFP | nramp1 | decreased infection rate by Legionella pneumophila, increased iron ion transport |
| DBS0237182 | [act15]: pakA | pakA | wild type |
| DBS0237183 | [act15]: pakA(K394A) | pakA | delayed development, development arrests at mound stage |
| DBS0237184 | [act15]: pakA[CA] | pakA | abolished aggregation |
| DBS0237185 | [act15]: pakA[G+K] | pakA | wild type |
| DBS0237188 | [act15]: pkaR(1-497) | pkaR | decreased fruiting body size, decreased intracellular cAMP level, precocious development |
| DBS0235442 | [act15]: pldB: GFP | pldB | abolished aggregation |
| DBS0237192 | [act15]: rblA | rblA | increased cell cycle length |
| SA604 | [act15]: sgkA: FLAG | sgkA | aberrant cytokinesis, increased resistance to carboplatin, increased resistance to cisplatin |
| DBS0238735 | [act15]: snfA(1-379): GFP | snfA | aberrant mitochondrion organization and biogenesis, decreased growth rate, decreased phototaxis, decreased stalk length, increased intracellular ATP level, increased number of mitochondria, increased stalk width |
| DBS0304457 | [act15]: sodA/ gcsA- | gcsA, sodA | wild type |
| DBS0237194 | [act15]: sodA: myc | sodA | abolished aggregation, decreased gene expression |
| DBS0237195 | [act15]: spkA: FLAG | spkA-1, spkA-2 | aberrant F-actin organization, aberrant aggregation, decreased cell polarity, decreased chemotaxis rate |
| AK1209 | [act15]: tagA(1-890) | tagA | multiple tips in mound |
| DBS0237198 | [act15]: torA | torA | abolished growth |
| DBS0237199 | [act15]: trrA | trrA | aberrant aggregation, decreased growth rate, decreased phagocytosis, delayed culmination |
| DBS0237200 | [act15]: vasP | vasP | increased basal F-actin level, increased filopodium formation |
| DBS0238218 | [act6]: TAP: GFP: lvsB | lvsB | wild type |
| DBS0237205 | [act6]: dia1 | dia1 | delayed aggregation |
| DBS0236905 | [act6]: mrps4 | mrps4 | precocious aggregation |
| DBS0235444 | [act6]: myc: eppA(S250A) | eppA | decreased growth rate, decreased intracellular cAMP level, delayed development |
| DBS0235445 | [act6]: myc: eppA(S325A) | eppA | decreased growth rate |
| DBS0266836 | [act6]: ptpB | ptpB | decreased fruiting body size, delayed aggregation |
| DBS0304410 | [act6]: srsA | srsA | aberrant fruiting body morphology, decreased gene expression, decreased sporulation, delayed aggregation, increased aggregate size, increased slug size |
| DBS0304460 | [act]: alrA/ gcsA- | alrA, gcsA | wild type |
| DBS0305081 | [dscB]: GFP: vamp7A(L35A) | vamp7A | increased localization of protein to the plasma membrane |
| DBS0304865 | [expl7]: expl7: GFP | expl7 | aberrant culminant morphology |
| DBS0237252 | [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0237253 | [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0236484 | [pkaC]: pkaC | pkaC | aberrant fruiting body morphology, decreased intracellular cAMP level, precocious development |
| DBS0237289 | [psmC1]: psmC1 | psmC1 | aberrant cytokinesis, delayed gene expression, delayed tip formation |
| DBS0304911 | [tre]: paxB | paxB | aberrant chemotaxis to folate, aberrant endocytosis, abolished sporulation, decreased cell motility, decreased cell-substrate adhesion, development arrests at mound stage, increased cell-cell adhesion |
| DBS0237938 | abpC-/ [act15]: GFP: abpC(9-148) | abpC | aberrant phototaxis |
| DBS0235426 | abpC-/ [act15]: abpC | abpC | wild type |
| DBS0237945 | abpC-/ [act15]: abpC(1-348: 449-857): GFP | abpC | aberrant F-actin organization, aberrant phototaxis |
| DBS0237946 | abpC-/ [act15]: abpC(1-556: 644-857): GFP | abpC | aberrant F-actin organization, aberrant phototaxis |
| DBS0237941 | abpC-/ [act15]: abpC(1-739): GFP | abpC | aberrant phototaxis |
| DBS0237786 | acrA-/ [act15]: acgA(1-401) | acgA, acrA | decreased gene expression, decreased prespore cell differentiation, decreased sporulation |
| DBS0235473 | alrA-/ [act15]: alrA | alrA | wild type |
| DBS0235488 | alxA-/ [act15]: FLAG: alxA | alxA | delayed development |
| DBS0235476 | alxA-/ [act15]: alxA(1-596): myc2 | alxA | wild type |
| DBS0235477 | alxA-/ [act15]: alxA(1-697): myc2 | alxA | wild type |
| DBS0235478 | alxA-/ [act15]: alxA(155-697): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235479 | alxA-/ [act15]: alxA(293-697): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235480 | alxA-/ [act15]: alxA(460-794): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235481 | alxA-/ [act15]: alxA(D310A/ N311A) | alxA | wild type |
| DBS0235482 | alxA-/ [act15]: alxA(Q181E/ Q183) | alxA | wild type |
| DBS0235483 | alxA-/ [act15]: alxA(S700A/ S704A/ S708A) | alxA | wild type |
| DBS0235484 | alxA-/ [act15]: alxA(S700D/ S704D/ S708D) | alxA | wild type |
| DBS0235485 | alxA-/ [act15]: alxA(Y315D) | alxA | wild type |
| DBS0235486 | alxA-/ [act15]: alxA(Y315F) | alxA | wild type |
| DBS0235487 | alxA-/ [act15]: alxA: myc2 | alxA | wild type |
| DBS0235501 | amtC-/ [act15]: cudA | amtC, cudA | delayed culmination |
| DBS0235502 | amtC-/ [ecmA]: cudA | amtC, cudA | delayed culmination |
| DBS0235503 | amtC-/ [pspA]: cudA | amtC, cudA | development arrests at slug stage |
| DBS0305085 | apm2-/ [dscB]: GFP: vamp7A | apm2, vamp7A | increased localization of protein to the plasma membrane |
| DBS0305083 | apm3-/ [dscB]: GFP: vamp7A | apm3, vamp7A | increased localization of protein to the plasma membrane |
| DBS0235510 | aprA-/ actin15: : aprA | aprA | aberrant fruiting body morphology, decreased growth rate |
| DBS0238085 | atg1-/ [act15]: atg1 | atg1 | wild type |
| DBS0238092 | atg1-/ [act15]: atg1(1-628) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238087 | atg1-/ [act15]: atg1(K36A) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238089 | atg1-/ [act15]: atg1(K36A/ 1-628) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0305978 | atg9-/ [act15]: GFP: atg9 | atg9 | wild type |
| DBS0305979 | atg9-/ [act15]: atg9: GFP | atg9 | wild type |
| DBS0302446 | cfaD-/ [act15]: cfaD | cfaD | wild type |
| DBS0302455 | chcA-/ [act15]: epnA: GFP | chcA, epnA | aberrant localization of a protein to coated pits |
| DBS0235604 | clc-/ [act15]: GFP-clc(146-194) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235605 | clc-/ [act15]: GFP-clc(85-124) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235607 | clc-/ [act15]GFP: clc(1-124) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0238320 | cpnA-/ [act15]: GFP: cpnA | cpnA | decreased culmination, delayed development, delayed response to hypo-osmotic stress |
| DBS0266761 | culB-/ [act15]: pkaC | culB, pkaC | abolished aggregation, abolished gene expression, abolished sporulation, precocious gene expression |
| DBS0235712 | dhkK-/ [act15]: dhkK(D1125N) | dhkK | aberrant fruiting body morphology |
| DBS0235719 | dia1-/ [act6]: trap1 | dia1, trap1 | aberrant aggregation, decreased fruiting body size |
| DBS0235903 | dimB-/ [act15]: dimA: GFP | dimA, dimB | abolished localization of protein to the nucleus |
| DBS0235904 | dimB-/ [act15]: dimB: GFP | dimB | wild type |
| DBS0302607 | disgorgin-/ [OE]: lvsA | DDB_G0280955, lvsA | aberrant contractile vacuole organization and biogenesis |
| DBS0302606 | disgorgin-/ [OE]: lvsD | DDB_G0280955, lvsD | wild type |
| DBS0302678 | disgorgin-/ [OE]: rab8A | DDB_G0280955, rab8A | aberrant contractile vacuole organization and biogenesis |
| DBS0238511 | drkC-/ [act15]: drkC(1-497): YFP | drkC | decreased phagocytosis |
| DBS0238513 | drkC-/ [act15]: drkC(K518R): YFP | drkC | decreased phagocytosis |
| DBS0238237 | dstA-/ GFP: dstA(237-707): ORF+ | dstA | abolished culmination, decreased stalk length |
| DBS0252824 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C | 2C, dstA | aberrant fruiting body morphology |
| DBS0252823 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E | 7E, dstA, hssB | wild type |
| DBS0252826 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165 | DDB_G0276165, dstA | aberrant fruiting body morphology |
| DBS0252825 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325 | DDB_G0282325, dstA | aberrant fruiting body morphology |
| DBS0252816 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA | dstA, hssA | wild type |
| DBS0252822 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssB | dstA, hssB | wild type |
| DBS0302598 | elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP | elmoA | decreased cell motility, increased phagocytosis |
| DBS0302591 | elmoA-/ [act15]: elmoA: GFP | elmoA | wild type |
| DBS0302457 | epnA-/ [act15]: GFP: epnA(253-677) | epnA | aberrant spore morphology, abolished localization of protein to coated pits, abolished localization of protein to the plasma membrane |
| DBS0302456 | epnA-/ [act15]: epnA(1-133): GFP | epnA | aberrant localization of a protein to coated pits |
| DBS0302474 | epnA-/ [act15]: epnA(R65A/ K78A): GFP | epnA | aberrant spore morphology, abolished localization of protein to coated pits, abolished localization of protein to the plasma membrane, abolished phosphatidylinositol-4, 5-bisphosphate binding |
| DBS0302475 | epnA-/ [act15]: epnA(T107A): GFP | epnA | aberrant spore morphology |
| DBS0302454 | epnA-/ [act15]: epnA: GFP | epnA | wild type |
| DBS0235948 | eppA-/ [act6]: myc: eppA | eppA | wild type |
| DBS0304905 | forC-/ [act15]: GFP-forC | forC | wild type |
| DBS0235971 | forH-/ [act15]: GFP: forH | forH | decreased cell motility, increased cell-substrate adhesion, increased filopodium formation |
| DBS0304440 | frmA-/ [unk]: GFP | frmA | aberrant development, abolished phototaxis, decreased gene expression, delayed development, increased cell-cell adhesion |
| DBS0305026 | gabT-[pkaC]: pkaC | gabT, pkaC | aberrant protein secretion |
| DBS0304912 | gbpC-/ [act15]: gbpC | gbpC | wild type |
| DBS0304917 | gbpC-/ [act15]: gbpC(1-1698: 2005-2631) | gbpC | decreased chemotaxis to cAMP |
| DBS0304918 | gbpC-/ [act15]: gbpC(311-2631) | gbpC | decreased chemotaxis to cAMP |
| DBS0304916 | gbpC-/ [act15]: gbpC(F1892A) | gbpC | decreased chemotaxis to cAMP |
| DBS0304915 | gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A) | gbpC | decreased chemotaxis to cAMP |
| DBS0304913 | gbpC-/ [act15]: gbpC(K342N) | gbpC | decreased chemotaxis to cAMP |
| DBS0304914 | gbpC-/ [act15]: gbpC(K905W) | gbpC | decreased chemotaxis to cAMP |
| DBS0235998 | gbpD-/ [act15]: gbpD | gbpD | aberrant F-actin organization, abolished aggregation, decreased chemotaxis rate, increased cell-substrate adhesion, increased lateral pseudopod formation |
| DBS0237190 | gdt1-/ [act15]: pkaR(G135E/ G261A) | gdt1, pkaR | abolished aggregation, increased gene expression |
| DBS0304985 | gefQ-/ [act15]: GFP: gefQ(172-654) | gefQ | abolished Ras guanyl-nucleotide exchange factor activity, decreased phototaxis |
| DBS0304986 | gefQ-/ [act15]: GFP: gefQ(910-1298) | gefQ | decreased phototaxis |
| DBS0238390 | gnt15-/ [act15]: FLAG: gnt15 | gnt15 | wild type |
| DBS0238391 | gnt15-/ [act15]: FLAG: gnt15 | gnt15 | wild type |
| DBS0236092 | gpaA-/ [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0236093 | gpaA-/ [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0236096 | gpaB-/ [act15]: gpaB | gpaB | abolished aggregation |
| DBS0266942 | gpaB-/ [act15]: gpaB | gpaB | delayed aggregation |
| DBS0266939 | gpaB-/ [act15]: gpaB(1-345): gpaD(337-345) | gpaB, gpaD | abolished aggregation |
| DBS0237137 | gpaB-/ [act15]: gpaB(D154V) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237138 | gpaB-/ [act15]: gpaB(E190G) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse |
| DBS0237139 | gpaB-/ [act15]: gpaB(I104S) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237140 | gpaB-/ [act15]: gpaB(L110S) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237141 | gpaB-/ [act15]: gpaB(L76P) | gpaB | abolished aggregation |
| DBS0237142 | gpaB-/ [act15]: gpaB(N74D) | gpaB | abolished aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237143 | gpaB-/ [act15]: gpaB(R64G) | gpaB | abolished aggregation, decreased chemotaxis rate |
| DBS0237144 | gpaB-/ [act15]: gpaB(S155P) | gpaB | abolished aggregation, decreased chemotaxis rate |
| DBS0236097 | gpaB-/ [gpaA]: gpaB | gpaB | abolished aggregation |
| DBS0236099 | gpaB-/ [gpaB]: gpaB | gpaB | wild type |
| DBS0266944 | gpaD-/ [act15]: gpaB | gpaB, gpaD | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| DBS0266946 | gpaD-/ [act15]: gpaB(1-345): gpaD(337-345) | gpaB, gpaD | aberrant fruiting body morphology, decreased accumulation of cGMP |
| DBS0266943 | gpaD-/ [act15]: gpaD | gpaD | wild type |
| DBS0266945 | gpaD-/ [act15]: gpaE | gpaD, gpaE | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| DBS0266947 | gpaD-/ [act15]: gpaE(1-339): gpaD(337-345) | gpaD, gpaE | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| DBS0266941 | gpaE-/ [act15]: gpaE | gpaE | precocious tip formation |
| DBS0266948 | gpaE-/ [act15]: gpaE(1-339): gpaD(337-345) | gpaD, gpaE | precocious tip formation |
| DBS0304815 | grlA-/ [act15]: grlA: GFP | grlA | aberrant tip formation |
| DBS0238866 | grlJ-/ [act15]: grlJ: GFP | grlJ | wild type |
| DBS0238687 | grpA-/ [act15]: grpA-FLAG | grpA | wild type |
| DBS0236152 | hcpAΔC-GFP | hcpA | abolished growth on bacterial plates, decreased growth rate in suspension |
| DBS0252702 | icmA-/ [act15]: TAP: YFP: rasG | icmA-1, icmA-2, rasG | abolished C-terminal protein amino acid methylation |
| DBS0238521 | icpA-/ [act15]: GFP: icpA(1-1013) | icpA | aberrant protein localization |
| DBS0236493 | krsA-/ [act15]: GFP: krsA | krsA | wild type |
| DBS0238721 | krsA-/ [act15]: GFP: krsA | krsA | wild type |
| DBS0238722 | krsA-/ [act15]: GFP: krsA(K49R) | krsA | aberrant streaming |
| DBS0238723 | krsA-/ [act15]: GFP: krsA(T173A) | krsA | abolished streaming |
| DBS0238725 | krsA-/ [act15]: GFP: krsA(deltaC) | krsA | aberrant streaming |
| DBS0238724 | krsA-/ [act15]: GFP: krsA(deltaKinase) | krsA | abolished streaming |
| DBS0238726 | krsA-/ [act15]: GFP: krsA(deltaNS) | krsA | abolished streaming |
| DBS0238109 | mekA-/ ppp4C-/ [act15]: FLAG: pppC | ppp4c | decreased aggregate size, precocious development |
| DBS0266674 | mhcA-/ [act15]: GFP: abpC(9-148) | abpC, mhcA | decreased pseudopod retraction, decreased uropod retraction |
| DBS0266675 | mhcA-/ [act15]: GFP: mhcA(E476K) | mhcA | decreased pseudopod retraction |
| DBS0236548 | mhcA-/ [act15]: GFP: pats1(2087-2351) | mhcA, pats1 | aberrant cytokinesis |
| DBS0236549 | mhcA-/ [act15]: limE(1-145): GFP | limE, mhcA | increased F-actin polymerization |
| DBS0238158 | mhcA-/ [act15]: mhcA(81-2116) | mhcA | decreased growth rate, development arrests at tipped mound stage |
| DBS0236550 | mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A) | mhcA | decreased filopodium formation |
| DBS0236551 | mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D) | mhcA | increased filopodium formation |
| DBS0238157 | mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H) | mhcA | decreased actin filament sliding |
| DBS0236557 | mhkA-/ [act15]: mhkA | mhkA | aberrant cytokinesis, decreased growth rate in suspension, decreased myosin II assembly, development arrests at mound stage |
| DBS0238058 | mlcE-/ [act15]: myc: mlcE | mlcE | wild type |
| DBS0266904 | mpl1-/ [act15]: flag: mpl1 | mpl1 | wild type |
| DBS0266889 | myoI-/ [act15]: GFP: myoI | myoI | wild type |
| DBS0266890 | myoI-/ [act15]: GFP: myoI(809-1154) | myoI | decreased phagocytosis |
| DBS0237617 | myoI-/ [act15]: gbpD | gbpD, myoI | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| DBS0236611 | noxA-/ [act15]: noxA: myc2 | noxA | aberrant fruiting body morphology |
| DBS0236702 | nxnA-/ [act15]: GFP: nxnB | nxnA, nxnB | development arrests at mound stage |
| DBS0238362 | p2xA-/ [act15]: p2xA: GFP | p2xA | wild type |
| DBS0236747 | pefB-/ noxA-/ [act15]: pefB | noxA, pefB | aberrant development |
| DBS0304869 | phg1A-/ [act15]: phg1a(1-276): phg1b(221-587) | phg1a, phg1b | decreased phagocytosis |
| DBS0304868 | phg1A-/ [act15]: phg1b | phg1a, phg1b | decreased cell-substrate adhesion, decreased phagocytosis, increased secretion of lysosomal enzyme |
| DBS0304870 | phg1A-/ [act15]: phg1b(1-220): phg1a(277-642) | phg1a, phg1b | decreased phagocytosis |
| DBS0237615 | phg2-/ [act15]: gbpD | gbpD, phg2 | aberrant cell morphology, abolished chemotaxis to cAMP, increased pseudopod formation |
| DBS0267125 | plc-/ [OE]: dagA(PH): GFP/ [OE]: plc | dagA, plc | aberrant protein localization, decreased chemotaxis to cAMP, increased CRAC localization to the plasma membrane |
| DBS0236797 | pldB-/ [act15]: pldB: GFP | pldB | abolished aggregation |
| DBS0236825 | ppk1-/ [act15]: ppk1 | ppk1 | wild type |
| DBS0238110 | ppp4C-/ [act15]: smkA | ppp4c, smkA | delayed development, development arrests at mound stage |
| DBS0238034 | proC-/ [unk]: FLAG: proC | proC | wild type |
| DBS0302356 | psrA-/ [act15]: FLAG: gskA | gskA, psrA | increased protein kinase activation |
| DBS0302357 | psrA-/ [act15]: gskA(K84M/ K85M) | gskA, psrA | decreased culmination, decreased gene expression, delayed development |
| DBS0237191 | racC-/ [act15]: CFP: racC | racC | increased chemoattractant-mediated F-actin polymerization |
| DBS0237614 | rasC-/ [act15]: gbpD | gbpD, rasC | aberrant cell morphology, increased cell-substrate adhesion |
| DBS0266697 | rasC-/ rasG-/ [act15]: carA | carA-1, carA-2, rasC, rasG | abolished activation of Rap GTPase activity, abolished cAMP-induced cGMP pulse, abolished chemotaxis to cAMP, abolished growth, abolished protein kinase B activation, decreased activation of adenylate cyclase, decreased growth rate |
| DBS0236859 | rasD(G12T) | rasD | development arrests at mound stage, development arrests at tipped mound stage |
| DBS0236864 | rasG-/ [rasG]: rasB | rasB, rasG | decreased growth rate in suspension |
| DBS0235706 | regA-/ [act15]: dhkK(D1125N) | dhkK, regA | aberrant fruiting body morphology, precocious development |
| DBS0236976 | talA- | talA | aberrant cell morphology, aberrant cytokinesis, decreased cell-substrate adhesion, decreased phagocytosis |
| DBS0304585 | talA-/ [act15]: FLAG: talB | talA, talB | decreased cell-substrate adhesion |
| DBS0237616 | talA-/ [act15]: gbpD | gbpD, talA | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| DBS0238395 | talA-/ [act15]: rapA(G12V) | rapA, talA | increased cell-substrate adhesion |
| DBS0304582 | talA-/ talB-/ [act15]: FLAG: talB | talA, talB | wild type |
| DBS0304586 | talB-/ [act15]: talA: GFP | talA, talB | aberrant fruiting body morphology |
| DBS0302383 | tsuA-/ [unk]: tsuA(1-1774): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302385 | tsuA-/ [unk]: tsuA(1-260): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302384 | tsuA-/ [unk]: tsuA(1774-2247): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302382 | tsuA-/ [unk]: tsuA(K34R): YFP | tsuA | decreased aggregate size, decreased fruiting body size |
| DBS0237033 | vasP-/ [act15]: GFP: vasP(1-264/ 285-380) | vasP | abolished filopodium formation |
| DBS0237836 | vasP-/ [act15]: YFP: wipA | vasP, wipA | decreased filopodium formation |
| DBS0237842 | vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG | vasP, wipA | increased filopodium formation |
| DBS0237040 | vasP-/ [act15]: vasP | vasP | decreased filopodium formation |
| DBS0237840 | vasP-/ [act15]: vasP | vasP | increased basal F-actin level, increased filopodium formation |
| DBS0237037 | vasP-/ [act15]: vasP(1-110: 231-380) | vasP | aberrant cytokinesis, decreased filopodium formation, increased basal F-actin level |
| DBS0237038 | vasP-/ [act15]: vasP(1-228) | vasP | decreased filopodium formation |
| DBS0237039 | vasP-/ [act15]: vasP(111-380) | vasP | increased basal F-actin level, increased filopodium formation |
| DBS0237812 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA | wasA | increased F-actin polymerization at the leading edge |
| DBS0237811 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A) | wasA | decreased F-actin polymerization, decreased F-actin polymerization at the leading edge |
| DBS0237820 | wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA | wasA, wipA | abolished chemotaxis |
| DBS0237091 | yakA-/ [crlA]: crlA | crlA, yakA | abolished growth |
